1Q21 Investor Update
FINANCIAL HIGHLIGHTS
(in US$ thousands)
P&L / Cash Flow
Combined Revenue (1)
Combined Adj. EBITDA (¹)
Interest Expense
Capital Expenditure
Balance Sheet
Cash
PP&E
Total Assets
Total Liabilities
Shareholder's Equity
1)
FY 2020A
197,909
(905)
13,831
42,885
61,111
114,400
792,591
470,715
321,876
Q2 2020A
33,012
(4,734)
1,684
7,426
42,350
116,157
423,636
181,661
241,975
Q3 2020A
54,162
4,226
4,308
9,342
42,142
116,023
741,428
394,619
346,809
Q4 2020A
81,799
9,468
7,042
3,177
61,111
114,400
792,591
470,715
321,876
Q1 2021A
92,492
10,410
7,573
7,232
176,498
119,971
941,605
488,454
453,151
Includes dispensary and manufacturing operations in Ohio. Consolidation of these businesses will follow closing of executed purchase option agreements which are subject to regulatory review.
2021 Guidance
Pro Forma(1)
$500-$530M
$95-$105M
13
Columbia Care™View entire presentation